ICU MEDICAL INC (ICUI) — insider trading
Health Care · NASDAQ
ICU MEDICAL INC (ICUI) has 49 reported SEC Form 4 insider transactions in our data, including 16 open-market sales among the most recent 49 (latest 2026-09-03).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-09-03 | Sanzone Virginia Ruth | Officer (VP, General Counsel) | Open-market sale | 692 | $171.52 | $118.7K | Form 4 |
| 2026-09-03 | Sanzone Virginia Ruth | Officer (VP, General Counsel) | Open-market sale | 724 | $169.53 | $122.7K | Form 4 |
| 2026-09-03 | Sanzone Virginia Ruth | Officer (VP, General Counsel) | Open-market sale | 1,238 | $168.44 | $208.5K | Form 4 |
| 2026-09-03 | Sanzone Virginia Ruth | Officer (VP, General Counsel) | Open-market sale | 2,202 | $167.67 | $369.2K | Form 4 |
| 2026-09-01 | Bonnell Brian Michael | Officer (Chief Financial Officer) | Open-market sale | 6,381 | $175.00 | $1.12M | Form 4 |
| 2026-08-31 | Bonnell Brian Michael | Officer (Chief Financial Officer) | Open-market sale | 1,113 | $173.91 | $193.6K | Form 4 |
| 2026-08-31 | Bonnell Brian Michael | Officer (Chief Financial Officer) | Open-market sale | 4,568 | $173.44 | $792.3K | Form 4 |
| 2026-08-31 | Bonnell Brian Michael | Officer (Chief Financial Officer) | Open-market sale | 1,914 | $172.12 | $329.4K | Form 4 |
| 2026-08-31 | Bonnell Brian Michael | Officer (Chief Financial Officer) | Open-market sale | 1,712 | $171.05 | $292.8K | Form 4 |
| 2026-08-13 | Woolson Daniel | Officer (VP, GM-Infusion Capital) | Open-market sale | 5,417 | $181.33 | $982.3K | Form 4 |
| 2026-08-12 | Sousa Ben | Officer (Chief Information Officer) | Open-market sale | 2,250 | $178.32 | $401.2K | Form 4 |
| 2026-08-11 | FINNEY ELISHA W | Director | Open-market sale | 378 | $182.48 | $69.0K | Form 4 |
| 2026-08-11 | Voigtlander Christian B. | Officer (Chief Operating Officer) | Open-market sale | 8,929 | $182.93 | $1.63M | Form 4 |
| 2026-05-22 | Woolson Daniel | Officer (President) | Open-market sale | 2,123 | $132.21 | $280.7K | Form 4 |
| 2026-05-14 | Sanzone Virginia Ruth | Officer (VP, General Counsel) | Open-market sale | 2,447 | $124.08 | $303.6K | Form 4 |
| 2026-05-13 | Greenberg David C. | Director | Grant / award / vesting (derivative) | 1,475 | — | $0 | Form 4 |
| 2026-05-13 | Greenberg David C. | Director | Option exercise / conversion (derivative) | 1,254 | — | $0 | Form 4 |
| 2026-05-13 | Greenberg David C. | Director | Option exercise / conversion | 1,254 | — | $0 | Form 4 |
| 2026-05-13 | Hoffmeister David F | Director | Grant / award / vesting (derivative) | 1,475 | — | $0 | Form 4 |
| 2026-05-13 | Hoffmeister David F | Director | Option exercise / conversion (derivative) | 1,254 | — | $0 | Form 4 |
| 2026-05-13 | Hoffmeister David F | Director | Option exercise / conversion | 1,254 | — | $0 | Form 4 |
| 2026-05-13 | Abbey Donald | Director | Grant / award / vesting (derivative) | 1,475 | — | $0 | Form 4 |
| 2026-05-13 | Abbey Donald | Director | Option exercise / conversion (derivative) | 1,254 | — | $0 | Form 4 |
| 2026-05-13 | Abbey Donald | Director | Option exercise / conversion | 1,254 | — | $0 | Form 4 |
| 2026-05-13 | FINNEY ELISHA W | Director | Grant / award / vesting (derivative) | 1,475 | — | $0 | Form 4 |
| 2026-05-13 | FINNEY ELISHA W | Director | Option exercise / conversion (derivative) | 1,254 | — | $0 | Form 4 |
| 2026-05-13 | FINNEY ELISHA W | Director | Option exercise / conversion | 1,254 | — | $0 | Form 4 |
| 2026-05-13 | Hernandez Laurie | Director | Grant / award / vesting (derivative) | 1,475 | — | $0 | Form 4 |
| 2026-05-13 | Hernandez Laurie | Director | Option exercise / conversion (derivative) | 1,254 | — | $0 | Form 4 |
| 2026-05-13 | Hernandez Laurie | Director | Option exercise / conversion | 1,254 | — | $0 | Form 4 |
| 2026-05-13 | KENNEDY KOLLEEN T | Director | Grant / award / vesting (derivative) | 1,475 | — | $0 | Form 4 |
| 2026-05-13 | KENNEDY KOLLEEN T | Director | Option exercise / conversion (derivative) | 1,254 | — | $0 | Form 4 |
| 2026-05-13 | KENNEDY KOLLEEN T | Director | Option exercise / conversion | 1,254 | — | $0 | Form 4 |
| 2026-05-12 | Greenberg David C. | Director | Option exercise / conversion (derivative) | 2,424 | — | $0 | Form 4 |
| 2026-05-12 | Greenberg David C. | Director | Open-market sale | 2,424 | $122.91 | $297.9K | Form 4 |
| 2026-05-12 | Greenberg David C. | Director | Option exercise / conversion | 2,424 | $101.06 | $245.0K | Form 4 |
| 2026-03-25 | Abbey Donald | Director | Other acquisition or disposition | 704 | — | $0 | Form 4 |
| 2026-03-15 | Sousa Ben | Officer (Chief Information Officer) | Option exercise / conversion (derivative) | 1,300 | — | $0 | Form 4 |
| 2026-03-15 | Sousa Ben | Officer (Chief Information Officer) | Shares withheld for taxes / exercise cost | 718 | $125.85 | $90.4K | Form 4 |
| 2026-03-15 | Sousa Ben | Officer (Chief Information Officer) | Option exercise / conversion | 1,300 | — | $0 | Form 4 |
| 2026-03-15 | Woolson Daniel | Officer (VP, GM-Infusion Capital) | Option exercise / conversion (derivative) | 2,924 | — | $0 | Form 4 |
| 2026-03-15 | Woolson Daniel | Officer (VP, GM-Infusion Capital) | Shares withheld for taxes / exercise cost | 1,295 | $125.85 | $163.0K | Form 4 |
| 2026-03-15 | Woolson Daniel | Officer (VP, GM-Infusion Capital) | Option exercise / conversion | 2,924 | — | $0 | Form 4 |
| 2026-03-15 | Voigtlander Christian B. | Officer (Chief Operating Officer) | Option exercise / conversion (derivative) | 11,400 | — | $0 | Form 4 |
| 2026-03-15 | Voigtlander Christian B. | Officer (Chief Operating Officer) | Option exercise / conversion (derivative) | 3,248 | — | $0 | Form 4 |
| 2026-03-15 | Voigtlander Christian B. | Officer (Chief Operating Officer) | Shares withheld for taxes / exercise cost | 1,795 | $125.85 | $225.9K | Form 4 |
| 2026-03-15 | Voigtlander Christian B. | Officer (Chief Operating Officer) | Option exercise / conversion | 3,248 | — | $0 | Form 4 |
| 2026-03-15 | Voigtlander Christian B. | Officer (Chief Operating Officer) | Shares withheld for taxes / exercise cost | 6,301 | $125.85 | $793.0K | Form 4 |
| 2026-03-15 | Voigtlander Christian B. | Officer (Chief Operating Officer) | Option exercise / conversion | 11,400 | — | $0 | Form 4 |
Ask the chat about ICUI's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: ICU MEDICAL INC (ICUI).
Last updated 2026-09-03 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.